Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Pacira BioSciences, Inc.

NASDAQ: PCRX · Life Sciences · 6 alerts · CIK 1396814

Share price
$36.48Close, Nov 16
Market cap
$1.46B
Shares outstanding
40.09MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Pacira BioSciences, Inc. filings on SEC EDGAR ↗

9:43 AM ET 8-K
M&A Deal

Pacira BioSciences M&A Deal with Viatris Inc.

Pacira BioSciences, Inc. completed its merger with Viatris Inc. on November 17, 2026, following a tender offer where Viatris acquired all outstanding shares for $36.50 per share in cash. As a result of the transaction, Pacira has become a wholly owned subsidiary of Viatris and entered into supplemental indentures to address its outstanding 2.125% Convertible Senior Notes due 2029.

Counterparty
Viatris Inc.
4:21 PM ET 8-K
Court & Legal Update

Pacira BioSciences Court & Legal Update

The U.S. Court of Appeals for the Ninth Circuit partially reversed a lower court ruling, determining that Pacira BioSciences owes royalties to the Research Development Foundation (RDF) for EXPAREL manufactured using its 200-liter process. This decision impacts a previous $28.3 million recovery Pacira received and remands the case to the District Court to recalculate interest owed on other portions of the judgment.

Counterparty
Research Development Foundation

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.